Menu
Urology & Andrology

Muscle Invasive Bladder Cancer (MIBC)

ICD-10 Code
C67.9_1

Clinical Criteria for Muscle Invasive Bladder Cancer (MIBC).

Clinical Presentation & Protocol

Patient Usually Complains Of

Patient presents with gross hematuria, frequency, urgency, and dysuria. Significant history of tobacco use. No flank pain or constitutional symptoms (weight loss, night sweats). Previous TURBT pathology confirmed high-grade urothelial carcinoma with muscularis propria invasion (cT2).

Clinical Examination Findings

Abdomen: Soft, non-tender, no palpable masses or bladder distension. External genitalia: Normal. DRE: No palpable prostatic induration or pelvic mass. Lymph nodes: No palpable inguinal or supraclavicular lymphadenopathy. Performance status: ECOG [0-1].

Treatment Protocol

Plan: Neoadjuvant cisplatin-based chemotherapy (NAC) followed by radical cystectomy with pelvic lymph node dissection and urinary diversion (ileal conduit vs. neobladder). Pre-operative staging CT chest/abdomen/pelvis completed. Nutritional optimization and smoking cessation counseling initiated.

Detailed clinical guide coming soon.